Global Journal of Medical Research, F: Diseases, Volume 23 Issue 2

12 Year 2023 Global Journal of Medical Research Volume XXIII Issue II Version I ( D ) F © 2023 Global Journals A Cancer Prevention and Treatment Opportunity 4. Bronte V, Brandau S, Chen SH, Colombo MP, Frey AB, Greten TF, et al. Recommendations for myeloid- derived suppressor cell nomenclature and characterization standards. Nat Commun . 2016 Jul 6; 7: 12150. doi: 10.1038/ncomms12150 5. Pawelec G, Verschoor CP, Ostrand-Rosenberg S. Myeloid-Derived Suppressor Cells: Not Only in Tumor Immunity. Front. Immunol . 2019; 10:1099. doi: 10.3389/fimmu.2019.01099 6. Bizymi N, Matthaiou AM, Matheakakis A, Voulgari I, Aresti N, Zavitsanou K, et al. New Perspectives on Myeloid-Derived Suppressor Cells and Their Emerging Role in Haematology. Journal of Clinical Medicine . 2022; 11(18): 5326. www.mdpi.com/ 2077-0383/11/18/5326 7. Veglia F, Sanseviero E, Gabrilovich DI. Myeloid- derived suppressor cells in the era of increasing myeloid cell diversity. Nat Rev Immunol . 2021; 21:485–498. doi.org/10.1038/s41577-020-00490-y 8. Nagatani Y, Funakoshi Y, Suto H, Imamura Y, Toyoda M, Kiyota N, et al. Immunosuppressive effects and mechanisms of three myeloid-derived suppressor cells subsets including monocytic- myeloid-derived suppressor cells, granulocytic- myeloid-derived suppressor cells, and immature- myeloid-derived suppressor cells . J Can Res Ther . 2021; 17: 1093-100. https://www.researchgate.net/ publication/354647025 9. Mohd Idris RA, Mussa A, Ahmad S, Al-Hatamleh MAI, Hassan R, Tengku Din TADAA, et al. The Effects of Tamoxifen on Tolerogenic Cells in Cancer. Biology . 2022; 11(8): 1225. doi.org/10.3390/ biology11081225 10. Kim WT, Ryu CJ. Cancer stem cell surface markers on normal stem cells. BMB Rep . 2017 Jun; 50(6): 285-298. doi: 10.5483/bmbrep.2017.50.6.039 11. Govallo VI. Immunology of Pregnancy and Cancer. Commack, N.Y: Nova Science Publishers; 1993:1- 310. ISBN-10. 1560720964 12. Zamorina SA, Troynich YN, Loginova NP, Charushina YA, Shardina KY, Timganova VP. Pregnancy-Associated Proteins as a Tool in the Therapy of Autoimmune Diseases and Alloimmune Disorders (Review). In: Rocha, A., Isaeva, E. (eds) Science and Global Challenges of the 21st Century - Science and Technology. Perm Forum 2021. Lecture Notes in Networks and Systems. 2022; vol 342. Springer, Cham. doi.org/10.1007/978-3-030- 89477-1_38 13. Dziadek M, Adamson E. Localization and synthesis of alpha-foetoprotein in post-implantation mouse embryos. J Embryol Exp Morphol . 1973; 43:289-313. PMID: 75937 14. Mizejewski GJ. (Ed.). Biological Activities of Alpha- Fetoprotein. In Biological Activities of Alpha- Fetoprotein. 1987; Vol. I and II. Boca Raton Florida Congresses: CRC Press, Inc. 15. Chereshnev VA, Rodionov SYu, Sherkasov VA, et al. Alpha-fetoprotein. [In Russian], Ekaterinburg, YuD RAS. 2004; 376 pages. 16. Terentiev AA, Moldogazieva NT. Alpha-fetoprotein: a renaissance. Tumour Biol . 2013 Aug; 34(4): 2075- 91. doi: 10.1007/s13277-013-0904-y 17. Lakhi N, Moretti M, eds. Alpha-Fetoprotein: Functions and Clinical Application. Protein Biochemistry, Synthesis, Structure and Cellular Functions. Hauppauge, New York: Nova Science Publisher’s, Inc.; 2016: 1-420. ISBN: 978-1-63484- 875-6 18. Pak VN. Alpha-fetoprotein and Its Receptor in Fixing the Cancer Brakes. Cambridge Scholars Publishing, Tyne, England; 2021: 1-209. ISBN: 1-5275-6716-8 19. Munson PV, Adamik J, Butterfield LH. Immunomodulatory impact of α -fetoprotein. Trends Immunol . 2022; Jun; 43(6): 438-448). doi: 10.1016/j.it.2022.04.001 20. Sologova SS, Zavadskiy SP, Mokhosoev IM, Moldogazieva NT. Short Linear Motifs Orchestrate Functioning of Human Proteins during Embryonic Development, Redox Regulation, and Cancer. Metabolites . 2022; 12(5): 464. doi.org/10.3390/ metabo12050464 21. Mizejewski GJ. Alpha-Fetoprotein as an Immunoregulator and Immune Response Modifier: Historical Background and Current Update. Journal of Immunology Research & Reports . 2022; SRC/JIRR-121. doi.org/10.47363/JIRR/2022( 2)120 22. Laan-Pütsep K, Wigzell H, Cotran P, Gidlund M. Human α -fetoprotein (AFP) causes a selective down regulation of monocyte MHC class II molecules without altering other induced or noninduced monocyte markers or functions in monocytoid cell lines. Cell Immunol. 1991; 133(2):506–1810. doi.org/10.1016/0008-8749( 91)90122-R 23. Terentiev AA, Moldogazieva NT, Levtsova OV, Maximenko DM, Borozdenko DA, Shaitan KV. Modeling of Three-Dimensional Structure of Human Alpha-Fetoprotein Complexed with Diethylstilbestrol: Docking and Molecular Dynamics Simulation Study. J. Bioinf. Comput. Biol . 2012; 10 (2): 1241012. doi.org/10.1142/S0219720012410120 24. Hsia JC, Deutsch HF. An in Vitro Model of Placental Transfer of Polyunsaturated Fatty Acids: The Albumin-Alpha-Fetoprotein Exchange System. In Biological Activities of Alpha-Fetoprotein. 1987; 1: 205–211. USA: CRC Press, Inc. 25. Esteban C, Trojan J, Macho A, Mishal Z, Lafarge- Frayssinet C, Uriel J. Activation of an Alpha- Fetoprotein/Receptor Pathway in Human Normal and Malignant Peripheral Blood Mononuclear Cells. Leukemia . 1993; 7 (11): 1807–16. PMID: 7544757 26. Torres JM, Laborda J, Naval J, et al. Expression of Alpha-Fetoprotein Receptors by Human T- Lymphocytes during Blastic Transformation. Mol.